← Leaderboards
Siu Kit Lam
Immunophotonics, Inc.
$2,400,000
Attributed
$2,400,000
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2021–24$2M$1.5M$1M$500K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$2,400,000 · 1
By mechanism
R44$2,400,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Clinical Trials”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$245,363,765
- Beth Baseler · Leidos Biomedical Research, Inc.$207,964,226
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$177,411,785
Research focus
Clinical TrialsAftercareAdvanced Breast CancerAblationAnimal DataAntigen-Presenting CellsAntigensAnti-Pd-1Analytical MethodBiocompatible MaterialsBiological MarkersBiopolymersBiotechnologyBloodBlood Chemical AnalysisBreast Cancer PatientCancer EtiologyCd8-Positive T-LymphocytesCellsCessation Of LifeChemical PropertyChemistryCirrhosisCollaborations
Grant awards (3)
Development of polymeric synthetic biomaterial IP-001 to potentiate asystemic immunotherapy of hepatocellular carcinoma via thermal ablation$780,148
R44 · FY2024 · CA · contact PI
Development of polymeric synthetic biomaterial IP-001 to potentiate asystemic immunotherapy of hepatocellular carcinoma via thermal ablation$1,219,852
R44 · FY2023 · CA · contact PI
Development of polymeric synthetic biomaterial IP-001 to potentiate asystemic immunotherapy of hepatocellular carcinoma via thermal ablation$400,000
R44 · FY2021 · CA · contact PI